Albemarle (NYSE:ALB) reported higher third-quarter sales and earnings as stronger lithium prices and demand for bromine products boosted results, while management raised its outlook for the specialties business and cut its capital spending plans. The company reported net sales of $1.6 billion, up 19% from a year earlier, and adjusted EBITDA of $646 million, an […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.